Apyx Medical
APYX
66 hedge funds and large institutions have $116M invested in Apyx Medical in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 30 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
35% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 17
20% more capital invested
Capital invested by funds: $97.2M → $116M (+$19.2M)
5.84% more ownership
Funds ownership: 45.22% → 51.06% (+5.8%)
15% less funds holding
Funds holding: 78 → 66 (-12)
40% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$9.1M |
| 2 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$6.89M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$2.16M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.09M |
| 5 |
RI
RTW Investments
New York
|
+$1.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.03M |
| 2 |
RA
Royce & Associates
New York
|
-$2.19M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.62M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$1.38M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.07M |
APYX Hedge Fund Activity: Q2 2019 in Review
66 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2019, worth a combined $116M — up 20% from $97.2M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of APYX and 18 opened new positions — a net loss of 12 holders — while 17 trimmed existing stakes and 23 added.
The largest buyer was BlackRock, adding an estimated $9.1M. The largest seller was Millennium Management, exiting entirely with an estimated $3.03M sold.
- 66 institutional investors held Apyx Medical (APYX) as of Q2 2019, down from 78 in Q1 2019.
- Funds reported $116M of Apyx Medical stock for Q2 2019, up 20% quarter-over-quarter.
- 18 funds opened new Apyx Medical positions in Q2 2019 and 30 closed out, a net change of -12 holders.
- The largest Apyx Medical buyer in Q2 2019 was BlackRock, an estimated $9.1M added.
- The largest Apyx Medical seller in Q2 2019 was Millennium Management, an estimated $3.03M sold.
Based on aggregated 13F filings for Q2 2019.